Skip to main content

Iodine-131: Not an Issue in the United States

By

potassium-iodide-120-tablets-source-naturals Here’s the bottom line first: no one in the United States is in danger from iodine-131, a radioactive isotope present in discharges from Fukushima Daiichi. No one needs potassium iodide to combat it because there is no danger of it. Got it? Let’s proceed:

NEI has a new fact sheet on iodine-131, about which Japan has issued a warning. This is from NEI’s update this morning and posted below:

Japanese authorities have advised Tokyo residents not to provide municipal drinking water to infants or use it in mixing powdered milk for infants because of abnormal levels of radioactive iodine (I-131) detected in the drinking water. One water sample (5,700 picocuries per liter) indicated approximately twice the Japanese government guideline and prompted the restriction for infants. In an emergency in the United States, state and local officials would closely monitor food and drinking water supplies and quarantine any contaminated supplies as needed to prevent public exposure. U.S. officials use pre-established guidelines for safe consumption of food and water set by the U.S. Food and Drug Administration.

Iodine-131 can roost in the thyroid and eventually cause cancer. It is considered dangerous to infants, children, pregnant women and fetuses, but not really to anyone (other than pregnant women) after age 20. Potassium Iodide is recommended when there is iodine-131 present – it floods the thyroid with iodine so iodine-131 finds no way to enter, but care has to be taken with it.

There are definite reasons not to fool around with potassium iodide. The American Association of Clinical Endocrinologists, the American Thyroid Association, The Endocrine Society, and the Society of Nuclear Medicine issued a letter to explain this:

However, KI [potassium iodide] should not be taken in the absence of a clear risk of exposure to a potentially dangerous level of radioactive iodine because potassium iodide can cause allergic reactions, skin rashes, salivary gland inflammation, hyperthyroidism or hypothyroidism in a small percentage of people.

So:

We discourage individuals needlessly purchasing or hoarding of KI in the United States. Moreover, since there is not a radiation emergency in the United States or its territories, we do not support the ingestion of KI prophylaxis at this time.

So there you go. Read the fact sheet, read the letter and be informed.

Labels:

Comments

Post a Comment

Popular posts from this blog

Activists' Claims Distort Facts about Advanced Reactor Design

By
Below is from our rapid response team . Yesterday, regional anti-nuclear organizations asked federal nuclear energy regulators to launch an investigation into what it claims are “newly identified flaws” in Westinghouse’s advanced reactor design, the AP1000. During a teleconference releasing a report on the subject, participants urged the Nuclear Regulatory Commission to suspend license reviews of proposed AP1000 reactors. In its news release, even the groups making these allegations provide conflicting information on its findings. In one instance, the groups cite “dozens of corrosion holes” at reactor vessels and in another says that eight holes have been documented. In all cases, there is another containment mechanism that would provide a barrier to radiation release. Below, we examine why these claims are unwarranted and why the AP1000 design certification process should continue as designated by the NRC. Myth: In the AP1000 reactor design, the gap between the shield bu...
23 comments
Read more

Fluor Invests in NuScale

By
You know, it’s kind of sad that no one is willing to invest in nuclear energy anymore. Wait, what? NuScale Power celebrated the news of its company-saving $30 million investment from Fluor Corp. Thursday morning with a press conference in Washington, D.C. Fluor is a design, engineering and construction company involved with some 20 plants in the 70s and 80s, but it has not held interest in a nuclear energy company until now. Fluor, which has deep roots in the nuclear industry, is betting big on small-scale nuclear energy with its NuScale investment. "It's become a serious contender in the last decade or so," John Hopkins, [Fluor’s group president in charge of new ventures], said. And that brings us to NuScale, which had run into some dark days – maybe not as dark as, say, Solyndra, but dire enough : Earlier this year, the Securities Exchange Commission filed an action against NuScale's lead investor, The Michael Kenwood Group. The firm "misap...
1 comment
Read more

Nuclear Utility Moves Up in Credit Ratings, Bank is "Comfortable with Nuclear Strategy"

By
Some positive signs that nuclear utilities can continue to receive positive ratings even while they finance new nuclear plants for the first time in decades: Wells Fargo upgrades SCANA to Outperform from Market Perform Wells analyst says, "YTD, SCG shares have underperformed the Regulated Electrics (total return +2% vs. +9%). Shares trade at 11.3X our 10E EPS, a modest discount to the peer group median of 11.8X. We view the valuation as attractive given a comparatively constructive regulatory environment and potential for above-average long-term EPS growth prospects ... Comfortable with Nuclear Strategy. SCG plans to participate in the development of two regulated nuclear units at a cost of $6.3B, raising legitimate concerns regarding financing and construction. We have carefully considered the risks and are comfortable with SCG’s strategy based on a highly constructive political & regulatory environment, manageable financing needs stretched out over 10 years, strong partners...
Post a Comment
Read more